Neuroscientific Biopharmaceuticals (ASX:NSB) Beginning Cash Position: A$7.27 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Neuroscientific Biopharmaceuticals Beginning Cash Position?

Neuroscientific Biopharmaceuticals ASX:NSB Beginning Cash Position is A$7.27 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Neuroscientific Biopharmaceuticals's Beginning Cash Position for the quarter that ended in Dec. 2025 was A$7.27 Mil.

Neuroscientific Biopharmaceuticals's quarterly Beginning Cash Position increased from Dec. 2024 (A$4.95 Mil) to Jun. 2025 (A$7.75 Mil) but then declined from Jun. 2025 (A$7.75 Mil) to Dec. 2025 (A$7.27 Mil).

Neuroscientific Biopharmaceuticals's annual Beginning Cash Position declined from Jun. 2023 (A$7.22 Mil) to Jun. 2024 (A$4.91 Mil) but then increased from Jun. 2024 (A$4.91 Mil) to Jun. 2025 (A$4.95 Mil).

Neuroscientific Biopharmaceuticals Beginning Cash Position Related Terms

Neuroscientific Biopharmaceuticals Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Neuroscientific Biopharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuroscientific Biopharmaceuticals Beginning Cash Position Chart

Neuroscientific Biopharmaceuticals Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beginning Cash Position
Get a 7-Day Free Trial 3.29 14.16 7.22 4.91 4.95

Neuroscientific Biopharmaceuticals Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.91 3.34 4.95 7.75 7.27

Neuroscientific Biopharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of A$7.27 Mil mean?
Neuroscientific Biopharmaceuticals (ASX:NSB) has a Beginning Cash Position of A$7.27 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Neuroscientific Biopharmaceuticals and its competitors.
Is Neuroscientific Biopharmaceuticals' Beginning Cash Position too high?
Neuroscientific Biopharmaceuticals' current Beginning Cash Position is A$7.27 Mil.
How does Neuroscientific Biopharmaceuticals' Beginning Cash Position compare to VRTX and REGN?
Neuroscientific Biopharmaceuticals' Beginning Cash Position of A$7.27 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Neuroscientific Biopharmaceuticals and its competitors. Neuroscientific Biopharmaceuticals's current Beginning Cash Position is A$7.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuroscientific Biopharmaceuticals stock overvalued right now?
Neuroscientific Biopharmaceuticals (ASX:NSB) has a current Beginning Cash Position of A$7.27 Mil. The current Beginning Cash Position is A$7.27 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Neuroscientific Biopharmaceuticals (ASX:NSB), the current Beginning Cash Position is A$7.27 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Neuroscientific Biopharmaceuticals Business Description

Address 216 Street Georges Terrace, Level 4, Perth, WA, AUS, 6000
Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and treatments for neurodegenerative diseases through preclinical studies of patented technologies.